AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-18 Cr | ₹8.89 Cr | ₹5.72 Cr | ₹11 Cr | ₹-2.30 Cr |
What is the latest Cash Flow from Operating Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹-18 Cr |
Mar2024 | ₹8.89 Cr |
Mar2023 | ₹5.72 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹-2.30 Cr |
How is Cash Flow from Operating Activities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-18 Cr | Negative | |
Mar2024 | ₹8.89 Cr | 55.23 | |
Mar2023 | ₹5.72 Cr | -50.10 | |
Mar2022 | ₹11 Cr | Positive | |
Mar2021 | ₹-2.30 Cr | - |
Compare Cash Flow from Operating Activities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹251.9 Cr | -8.3% | -9.2% | -49.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -8.3% |
-9.2% |
-49.9% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses